Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents

AIDS

Volumn 13, Issue 7, 1999, Pages 779-789

  Böhler, Thomas ^b   Walcher, Judith ^b   Hölzl Wenig, Gabi ^b   Geiss, Magdalena ^b   Buchholz, Bernd ^b   Linde, Richard ^b   Debatin, Klaus Michael ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b NONE

Author keywords

Antiretroviral therapy; Apoptosis; HIV; T cell reconstitution

Indexed keywords

ANTIRETROVIRUS AGENT; CD34 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; INDINAVIR; PADGEM PROTEIN; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT; ANOREXIA; APOPTOSIS; ARTICLE; BONE MARROW; CELL REGENERATION; CHILD; CLINICAL ARTICLE; COLIC; CONTROLLED STUDY; DIARRHEA; DRUG TOXICITY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HEMATURIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MEMORY CELL; MONONUCLEAR CELL; NAUSEA; PAIN; PRIORITY JOURNAL; PYURIA; T LYMPHOCYTE ACTIVATION; THYMUS; VIRUS REPLICATION; WASTING SYNDROME;

ADOLESCENT; ANTI-HIV AGENTS; APOPTOSIS; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; INFANT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; RNA, VIRAL; T-LYMPHOCYTES;

EID: 3042799131     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199905070-00006     Document Type: Article

References (39)

1. 1. Levy J: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993, 57:183-289.
2. 2. Gougeon ML: Does apoptosis contribute to CD4 cell depletion in human immunodeficiency virus infection? Cell Death Differ 1995, 2:1-8.
3. 3. Debatin KM, Fahrig-Faissner A, Enenkel-Stoodt S, Kreuz W, Benner A, Krammer PH: High expression of APO-1 (CD95) on T-lymphocytes from human immunodeficiency virus infected children. Blood 1994, 83:3101-3103.
4. 4. Bäumler CB, Böhler I, Herr I, Benner A, Krammer PH, Debatin K-M: Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood 1996, 88:1741-1746.
5. 5. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA, Herzenberg IA: Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 1995, 181:2029-2036.
6. 6. Gehri R, Hahn S, Rothen M, Steuerwald M, Nuesch R, Erb P: The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and rule in the depletion of T cells. AIDS 1996, 10:9-16
7. 7. Silvestris F, Cafforio P, Frassanito MA, et al.: Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis. AIDS 1996, 10:131-141.
8. 8. Dhein J, Walczak H, Bäumler C, Debatin KM, Krammer PH: Autocrine T cell suicide mediated by APO-1 (Fas/CD95). Nature 1995, 373:438-441.
9. 9. Böhler T, Bäumler C, Herr I, Groll A, Kurz M, Debatin K-M: Activation of the CD95 system increases with disease progression in human immunodeficiency virus type-1-infected children and adolescents. Pediatr Infect Dis J 1997, 16:754-759.
10. 10. Böhler T, Nedel S, Debatin K-M: CD95-induced apoptosis contributes to loss of primed/memory but not resting/naive T cells in children infected with human immunodeficiency virus type 1. Pediatr Res 1997, 41:878-885.
11. 11. Kelleher AD, Carr A, Zaunders J, Cooper DA; Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996, 173:321-329.
12. 12 Connors M, Kovacs JA, Krevat S, et al.: HIV infection induced changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nature Med 1997, 3:533-540.
13. 13. Böhler T, Herr I, Debatin K-M, Geiss M, Haas J: Downregulation of increased CD95 (APO-1/Fas) ligand in T cells from human immunodeficiency virus type-1-infected after antiretroviral therapy. Blood 1997, 90:886-887.
14. nd Edn. Edited by Friese K, Kachel W. Berlin: Springer; 1998:162-188.
15. + T-cell determinations in persons with human immunodeficiency virus infection. MMWR 1992, 41(RR-8):1-17.
16. 16. Pachl C, Todd JA, Kern DG, et al.: Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr 1995, 8;446-454.
17. 17. Krowka JF, Cuevas B, Maron DC, Steimer KS, Ascher MS, Sheppard HW: Expression of CD69 after in vitro stimulation; a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals. J Acquir Immune Defic Syndr 1996, 11:95-104.
18. + cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994, 22:1003-1010.
19. 19. Bárcena A, Muench MO, Galy AHM, et al.: Phenotypic and functional analysis of T-cell precursors in the human fetal liver and thymus: CD7 expression in the early stages of T-and myeloid-cell development. Blood 1993, 82:3401-3414.
20. 20. Palella FI, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998, 338:853-860.
21. 21. Autran B, Carcelain G, Li TS, et al.: Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112-116.
22. 22. Plaeger-Marshall S, Hultin P, Bertolli J, et al.: Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children. J Acquir Immune Defic Syndr 1993, 6:984-993.
23. 23. Roederer M, Herzenberg LA, Herzenberg LA: Changes in antigen densities on leukocyte subsets correlate with progression of HIV disease. Int Immunol 1996, 8:1-11.
24. 24. Rosenzweig M, Clark DP, Gaulton GN: Selective thymocyte depletion in neonatal HIV-1 thymic infection. AIDS 1993, 7:1601-1603.
25. 25. Kourlis AP, Ibegbu C, Nahmias AJ, et al.: Early progression of disease in HIV-infected infants with thymus dysfunction. N Engl J Med 1996, 335:1431-1436.
26. 26. Mackall CI, Fleisher TA, Brown MR, et al.: Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995, 332:143-149.
27. 27. Heitger A, Neu N, Kern H, et al.: Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogenic bone marrow transplantation. Blood 1997, 90:850-857.
28. 28. Whiters-Ward ES, Amado RG, Koka PS, et al.: Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy. Nature Med 1997, 3:1102-1109.
29. 29. Louache F. Henri A, Bettaieb A, et al.: Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 1992, 80:2991-2999.
30. 30. Bahner I, Kearns K, Coutinho S, Leonard EH, Kohn DB: Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma. Blood 1997, 90:1787-1798.
31. 31. Manegold C, Jablonowski H, Armbrecht C, Strohmeyer G, Pietsch T: Serum levels of stem cell factor are increased in asymptomatic human immunodeficiency virus-infected patients and are associated with prolonged survival. Blood 1995, 86:243-249.
32. 32. Nielsen SD, Dam-Larsen S, Nielsen C, Wantzin P, Mathiesen L, Hansen J-ES: Recombinant human granulocyte colony-stimulating factor increases circulating CD34-positive cells in patients with AIDS. Ann Hematol 1997, 74:215-220.
33. 33. Stahnke K, Hecker S, Kohne E, Debatin K-M: CD95 (APO-1/Fas)-mediated apoptosis in cytokine-activated hematopoietic cells. Exp Hematol 1998; 26:844-850.
34. 34. Bruno L, Res P, Dessing M, Cella M, Spits H: Identification of a committed T cell precursor population in adult human peripheral blood. J Exp Med 1997, 185:875-884.
35. 35. Levitz SM: Improvement in CD4+ cell counts despite persistently delectable HIV load. N Engl J Med 1998, 338:1074-1075.
36. 36. Kaufmann D, Pantaleo G, Sudre P, Telenti A, for the Swiss HIV Cohort Study: CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Lancet 1998, 351:723-724.
37. 37. Debatin K-M, Süss D, Krammer PH: Differential expression of APO-1 on human thymocytes: implications for negative selection? Eur J Immunol 1994, 24:753-758.
38. 38. Haas J, Geiss M, Böhler T: False-negative polymerase chain reaction-based diagnosis of human immunodeficiency virus (HIV) type 1 in children infected with HIV strains of African origin. J Infect Dis 1996, 174:244-245.
39. 39. Centers for Disease Control: 1994 revided classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994, 43(RR-12):1-10.